½üÈÕ£¬Ð±¦GGÐÔÃü¿ÆÑ§Ñ§ÔºÕÅÖÒ»Ô½ÌÊÚ¿ÎÌâ×éÔÚ°×Ѫ²¡¸Éϸ°û×ÔÎÒ¸üлúÀíµÄµ÷¿Ø×êÑÐÖлñµÃ×îнøÕ¹£º·¢ÏÖ¸ßЧ±í°×miR-30e-5p¿ÉÔÚÓ×ÊóÌåÄÚÓÐЧÒÖÔì°×Ѫ²¡¸Éϸ°ûµÄ³É³¤£¬µ¢¸éËèϵ°×Ѫ²¡Ä£ÐÍÓ×ÊóµÄÉú¼Æ¹¦·ò£¬²¢Ã÷È·Æä¾ßÌå·Ö×Ó×÷ÓûúÔì¡£ÓйØ×êÑгɾÍÔÚ¹ú¼ÊѪҺ²¡Àí¼°ÉúÀíѧÆÚ¿¯¡¶Haematologica¡·Éϰ䷢ÌâΪ¡°miR-30e-5p regulates leukemia stem cell self-renewal through the Cyb561/ROS signaling pathway¡±µÄ×êÑÐÂÛÎÄ£¨ÂÛÎÄÁ´½Ó£ºhttps://haematologica.org/article/view/haematol.2023.282837£©¡£¸ÃÔÓÖ¾µÄ×îÐÂÓ°ÏìÒò×ÓΪ10.1¡£¸Ã×êÑгɾÍÊÇÓÉб¦GGÓ뻪ÖпƼ¼´óѧͬ¼ÃҽѧԺ¡¢ÖÐÄÏ´óÑ§ÏæÑŶþÔº¼°ÃÀ¹úÒÁÀûŵÒÁ´óѧ֥¼Ó¸ç·ÖУµÈ¹úÄÚ±í¶à¼Ò¿ÆÑлú¹¹ºÏ×÷£¬Ð±¦GGÕÅÖÒ»Ô½ÌÊÚΪ¹²Í¬Í¨Ñ¶×÷Õߣ¬ÐÔÃüѧԺ˶ʿ×êÑÐÉú¸ðÑÔÎÄΪÂÛÎĵÚÒ»×÷Õߣ¬Ð±¦GGΪµÚһʵÏÖµ¥Ôª¡£

¼±ÐÔËèϵ°×Ѫ²¡£¨Acute myeloid leukemia, AML£©ÊÇÒ»ÀàÔìѪϵͳµÄ¶ñÐÔÖ×Áö¼²²¡£¬ÖØÒªÊÇÓÉÓÚÔìѪ¸É×æÏ¸°ûÖеÄijЩ»ùÒò²úÉúÍ»±ä»ò»ùÒò×é³ÁÅŶø²úÉúµÄ°×Ѫ²¡¸Éϸ°ûËùÖ¡£¹ÌÈ»½üÄêÀ´¶ÔAMLÒ½ÖÎˮƽÒÑÓп϶¨Ë®Æ½µÄÌá¸ß£¬µ«³ÉÈËAMLµÄ5ÄêÎÞ²¡Éú¼ÆÂʽöԼΪ24%¡£Òò¶ø£¬×êÑа×Ѫ²¡¸Éϸ°û×ÔÎÒ¸üеķÖ×Ó»úÀí¶ÔAMLµÄÁÙ´²Ò½ÖÎÏÔµÃÓÈΪ³ÁÒªºÍ»ð¼±¡£¶àÏî×êÑÐÅú×¢£¬°×Ѫ²¡¸Éϸ°ûµÄ×ÔÎÒ¸üÐÂÄÜÁ¦¿ÉÏÔÖøÓ°ÏìAMLµÄ²úÉú·¢Õ¹¡£Í¬Ê±£¬ÓÉÓÚÕý³£ÔìѪ¸Éϸ°ûºÍ°×Ѫ²¡¸Éϸ°ûÔÚ×ÔÎÒ¸üÐÂÄÜÁ¦Éϵĵ÷¿ØÓµÓÐÖî¶àÀàËÆÐÔ£¬Òò¶ø°×Ѫ²¡¸Éϸ°ûͨ³£ÄÑÒÔÓÃͨÀý¼¿Á©»¯ÁƼ¿Á©½øÐиù³ý¡£¸ÃÂÛÎÄÔÚǰÆÚ×êÑлù´¡ÉÏ£¬·¢ÏÖmiR-30e-5pÔÚ²»Ó°ÏìÕý³£ÔìѪ¸Éϸ°ûÉúÀíÖ°ÄܵÄǰÌáÏ£¬¿ÉÏÔÖøÒÖÔì°×Ѫ²¡¸Éϸ°ûµÄ²úÉú·¢Õ¹£¬µ¢¸é°×Ѫ²¡Ä£ÐÍÓ×ÊóµÄÉú¼Æ¹¦·ò¡£Í¨¹ýÉúÎïÐÅϢѧµÈ¶àÖÖ¼¼Êõ¼¿Á©£¬×êÑз¢ÏÖ£ºÔÚ°×Ѫ²¡¸Éϸ°ûÖÐmiR-30e-5pÊÇͨ¹ýµ÷¿ØÏÂÓΰзÖ×ÓCyb561£¬Ó°Ïì°×Ѫ²¡¸Éϸ°ûÄÚ¿¹»µÑªËá¼°¹Èë׸ÊëĵÄˮƽ½ø¶øµ÷¿Ø°ûÄÚROS£¬×îÖÕ¶Ô°×Ѫ²¡¸Éϸ°ûµÄϸ°ûÖÜÆÚºÍϸ°ûµòÍö²úÉú³ÁÒªµ÷½Ú×÷Óá£

¸Ã×êÑй¤×÷µÃµ½Á˹ú¶ÈÌìÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿¡¢ÉϺ£ÊпÆÎ¯ÃæÉÏÏîÄ¿¡¢ÉϺ£ÊнÌί¡°¶«·½Ñ§Õß¡±´òËã¼°¸ú×Ù´òËãµÈÔÞÖúºÍÖ§³Ö¡£